Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
57.09M | 102.36M | 158.60M | 115.15M | 95.07M | Gross Profit |
9.51M | 19.22M | 28.90M | 10.66M | 4.31M | EBIT |
-5.30M | 1.86M | 23.75M | 5.55M | 207.00K | EBITDA |
-3.21M | 3.21M | 27.26M | 10.08M | 3.47M | Net Income Common Stockholders |
-9.52M | 466.00K | 16.52M | 5.01M | -717.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.75M | 13.14M | 11.26M | 4.64M | 4.96M | Total Assets |
70.59M | 85.17M | 96.32M | 82.51M | 75.03M | Total Debt |
2.26M | 4.42M | 9.55M | 12.02M | 17.16M | Net Debt |
-5.49M | -8.72M | -1.71M | 7.38M | 12.20M | Total Liabilities |
20.59M | 28.52M | 40.20M | 46.24M | 46.13M | Stockholders Equity |
50.00M | 56.65M | 56.13M | 36.27M | 28.89M |
Cash Flow | Free Cash Flow | |||
-2.92M | 7.43M | 8.84M | 4.94M | 3.86M | Operating Cash Flow |
-996.00K | 11.40M | 10.75M | 5.82M | 4.54M | Investing Cash Flow |
-1.94M | -4.00M | -1.78M | -844.00K | -1.09M | Financing Cash Flow |
-2.85M | -5.54M | -2.35M | -5.66M | -2.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | AU$32.81B | 16.56 | 20.24% | 5.64% | -1.42% | 25.16% | |
64 Neutral | $3.23B | 1,418.92 | -36.53% | 11.24% | -28.50% | -532.61% | |
54 Neutral | $2.60B | 79.97 | 2.82% | ― | 3.23% | 402.60% | |
53 Neutral | AU$11.96M | ― | -17.85% | 2.79% | -29.47% | -2033.87% | |
51 Neutral | $2.04B | -1.15 | -21.24% | 3.95% | 2.91% | -30.44% | |
40 Underperform | $66.17M | ― | -46.99% | ― | ― | -23.51% |
Magontec Limited announced a change in the director’s interest, specifically regarding Nicholas William Andrews. The change involves an increase in unlisted performance rights, which are part of Mr. Andrews’ variable remuneration package approved at the recent AGM. This adjustment in securities holdings reflects the company’s ongoing commitment to aligning executive compensation with performance metrics, potentially impacting stakeholder perceptions positively.
Magontec Limited held its 42nd Annual General Meeting, where key topics included the approval of a share buyback from Qinghai Salt Lake Magnesium Co Ltd and the company’s strategic focus for 2025. The meeting also covered formal business such as the adoption of the remuneration report and the re-election of a director, with no objections or questions raised by shareholders, indicating smooth proceedings and shareholder alignment with the company’s direction.
Magontec Limited held its Annual General Meeting on May 7, 2025, where all resolutions were passed by a poll. The successful resolutions included the re-election of directors and the approval of performance rights for the Executive Director and CEO, indicating strong shareholder support and potentially positive implications for the company’s governance and strategic direction.
Magontec Limited’s recent AGM highlighted a significant shift in its shareholder structure following the buyback and cancellation of shares held by Qinghai Salt Lake Magnesium Co Ltd, reducing shares by 28.5% and increasing ownership for remaining shareholders by 40%. This strategic move allows the company to focus on future business activities, despite a slight decline in gross profit for the first quarter of 2025 compared to the previous year.
Magontec Limited has issued a proxy form for its 2025 Annual General Meeting, emphasizing the importance of shareholder participation in the voting process. The document outlines the procedures for appointing a proxy, either online or by completing the form, and provides instructions for directing proxies on how to vote on various resolutions, including the adoption of the remuneration report and the re-election of directors.
Magontec Limited has announced its 2025 Annual General Meeting (AGM), which will take place in person on May 7, 2025, at Cliftons Event Solutions in Sydney. The meeting will cover the financial report for the year ended December 31, 2024, and include votes on several resolutions, such as the re-election of directors and the approval of performance rights for the Executive Chairman. Shareholders are encouraged to attend in person or appoint a proxy to vote on their behalf.
Magontec Limited has announced its 2025 Annual General Meeting (AGM), scheduled for May 7, 2025, at 11:00 am AEST. Shareholders will receive AGM materials, including the Notice of Annual General Meeting and a proxy voting form, either by physical post or electronic mail. The meeting will be held at Cliftons Events Solutions in Sydney, and shareholders can participate in person or cast their votes prior to the meeting through mail, online, or via smartphone.